A Study of Tirzepatide (LY3298176) Once a Week Versus Insulin Glargine Once a Day in Participants With Type 2 Diabetes and Increased Cardiovascular Risk
Clinical trial NCT03730662 · COMPLETED
Trial details
- NCT number
- NCT03730662
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-11-20
- Primary completion
- 2021-01-22
- Enrollment
- 2002
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.